Prenetics Global (PRE) Income from Continuing Operations (2021 - 2026)
Prenetics Global's (PRE) quarterly Income from Continuing Operations came in at -$9.1 million in Q2 2026, up 3.02% year-over-year from -$8.8 million in Q2 2025, and up 66.72% quarter-over-quarter from -$27.3 million in Q1 2026.
Analysis
Prenetics Global (PRE) Income from Continuing Operations (2021 - 2026) Analysis & Trends
Prenetics Global (PRE) has reported Income from Continuing Operations for 6 consecutive years, with -$9.1 million the latest figure, recorded in Q2 2026.
- On a quarterly basis, Income from Continuing Operations rose 3.02% year-over-year to -$9.1 million in Q2 2026; TTM through Jun 2026 was -$44.1 million, a 15.86% decrease from a year earlier, with the FY2025 full-year figure at $744538.7, up 101.95% from the prior year.
- Income from Continuing Operations was -$9.1 million for Q2 2026 at Prenetics Global, up from -$27.3 million in the prior quarter.
- Over five years, Income from Continuing Operations peaked at -$1.0 million in Q4 2025 and troughed at -$226.1 million in Q4 2022.
- A 5-year average of -$34.8 million and a median of -$12.5 million in 2023 frame the typical range for Income from Continuing Operations.
- Across the five-year window, Income from Continuing Operations slumped 2907.33% in 2022 and soared 92.12% in 2025, its largest moves.
- Over 5 years, Income from Continuing Operations stood at -$226.1 million in 2022, then surged by 75.1% to -$56.3 million in 2023, then surged by 77.07% to -$12.9 million in 2024, then soared by 92.12% to -$1.0 million in 2025, then sank by 792.63% to -$9.1 million in 2026.
- The last three Income from Continuing Operations figures came in at -$9.1 million (Q2 2026), -$27.3 million (Q1 2026), and -$1.0 million (Q4 2025), per Business Quant data.
Peer Set
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Income (Continuing) (Qtr) |
|---|---|---|---|---|---|
| 1 | GE HealthCare Technologies | 28.97 Bn | 27.09 Bn | 2.18 Bn | 574.00 Mn |
| 2 | Lantheus Holdings | 6.56 Bn | 5.97 Bn | 241.86 Mn | 75.03 Mn |
| 3 | Heartflow | 4.40 Bn | 4.03 Bn | 53.19 Mn | -15.74 Mn |
| 4 | Neogen | 2.83 Bn | 2.64 Bn | 107.80 Mn | -10.50 Mn |
| 5 | Butterfly Network | 1.88 Bn | 1.75 Bn | 23.29 Mn | -12.91 Mn |
| 6 | Ceribell | 931.50 Mn | 802.24 Mn | 25.94 Mn | -19.27 Mn |
| 7 | Varex Imaging | 779.32 Mn | 694.02 Mn | 76.70 Mn | 15.90 Mn |
| 8 | Anbio Biotechnology | 755.43 Mn | 743.53 Mn | - | - |
| 9 | QuidelOrtho | 725.35 Mn | 601.95 Mn | - | - |
| 10 | Prenetics Global | 339.92 Mn | 280.78 Mn | 30.20 Mn | -9.08 Mn |
Historic Data
Download Data
Historic Data
| Date | Value |
|---|---|
| Jun 30, 2026 | -9.08 Mn |
| Mar 31, 2026 | -27.28 Mn |
| Dec 31, 2025 | -1.02 Mn |
| Sep 30, 2025 | -6.77 Mn |
| Jun 30, 2025 | -9.36 Mn |
| Mar 31, 2025 | -5.99 Mn |
| Dec 31, 2024 | -12.91 Mn |
| Sep 30, 2024 | -9.85 Mn |
| Jun 30, 2024 | -8.91 Mn |
| Mar 31, 2024 | -9.60 Mn |
| Dec 31, 2023 | -56.28 Mn |
| Sep 30, 2023 | -12.01 Mn |
| Jun 30, 2023 | -18.53 Mn |
| Mar 31, 2023 | -13.87 Mn |
| Dec 31, 2022 | -226.07 Mn |
| Sep 30, 2022 | -20.29 Mn |
| Jun 30, 2022 | -148.52 Mn |
| Mar 31, 2022 | -29.65 Mn |
| Dec 31, 2021 | -213.99 Mn |
| Sep 30, 2021 | -78.72 Mn |